Selected private financing rounds by European biotech companies this year. (See BioCentury Oct. 13 for some European venture funds.)

Acadia Pharmaceuticals (formerly Receptor Technologies) $13.5M Danish subsidiary of San Diego high throughput screening company raises funds from Danish consortium including Dansk Kapitalanlog, BankInvest, Lonmodtagernes Dyrtidsfond and Kommuernes Pensionforsikring and Vokstfonden, Denmark's business development finance agency
AdProTech £5M Therapeutic protein targeting company out of SmithKline Beecham, backed by 3i, Prelude Trust & Alta Berkeley Associates
Aquaculture Vaccines £1M Fish vaccines developer for fish farming backed by 3i
BioVector Therapeutics $18M French drug delivery company enjoys oversubscribed private placement prior to IPO. New investors include Dresdener Kleinwort Benson, BNP, Gestion, Mercury Asset Management and Reabourne Merlin Life Science Fund